Optimal mass on the parabolic-elliptic-ODE minimal chemotaxis-haptotaxis in R 2
Physica Scripta · 01.09.2023 · 98 (9) · 095223
DOI: 10.1088/1402-4896/aceba0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physica Scripta, online erschienen am 14.08.2023. Verfasst von Siying Li und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Project of Education Department of Liaoning Province, Liaoning Revitalization Talents Program.
Abstract (Originalsprache)
In this paper, we study the Cauchy problem to a chemotaxis-haptotaxis model describing cancer invasion in R 2 . The main feature is to prove that 8 π is the critical mass on initial data for distinguishing existence and blow-up of solutions to the model. Namely, when the initial mass is less than 8 π , we prove global existence of solutions by constructing a proper free energy and using the Brezis-Merle type inequality. On the contrary, the finite time blow-up of solutions may occur if the initial mass is greater than 8 π and the initial second moment is small enough. Comparing to the classical Keller-Segel model, we find that the haptotaxis has no effect on the critical mass of the model.
Förderung
- National Natural Science Foundation of China
- Key Project of Education Department of Liaoning Province
- Liaoning Revitalization Talents Program
Zitieren
APA
Li, S., & Wang, J. (2023). Optimal mass on the parabolic-elliptic-ODE minimal chemotaxis-haptotaxis in R 2. Physica Scripta, 98(9), 095223. https://doi.org/10.1088/1402-4896/aceba0
Vancouver
Li S, Wang J. Optimal mass on the parabolic-elliptic-ODE minimal chemotaxis-haptotaxis in R 2. Physica Scripta. 2023;98(9):095223. doi:10.1088/1402-4896/aceba0
BibTeX
@article{Li2023,
author = {Li, Siying and Wang, Jinhuan},
title = {Optimal mass on the parabolic-elliptic-ODE minimal chemotaxis-haptotaxis in R 2},
journal = {Physica Scripta},
year = {2023},
volume = {98},
number = {9},
pages = {095223},
doi = {10.1088/1402-4896/aceba0}
}
EUVIMED